Cannabis Law Report

OCTOBER 4, 2021

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

MARCH 2, 2024

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments.

Legalization 105

Legalization Epilepsy Clinical Trials THC 105

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. According to a 2016 study , about 39.3%

Medicine 98

Medicine Treatment Patients Data 98

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.” Minnesota Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Veriheal

AUGUST 21, 2023

On June 22, 2023, Mets owner Steve Cohen and his wife made headlines with his remarkable donation of $5 million donated to the Multidisciplinary Association for Psychedelic Studies (MAPS). If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 90

Therapy Research and Development Treatment Environment 90

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! Verify your email address.

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Veriheal

MAY 22, 2023

In April 2023, Maine’s Office of Cannabis Policy (OCP) reported an exodus of about 1350 cannabis primary caregivers from the state’s medical marijuana market between 2021 to January 2023. Medical marijuana primary caregivers, or simply caregivers , are certified personnel who assist a qualifying patient with medical cannabis use.

Programs 90

Programs Patients Cannabis Policy 90

Veriheal

DECEMBER 14, 2023

This stigma has been problematic for cannabis consumers for years and often leads to unfair stereotypes against people who benefit from cannabis treatment for mental or physical health issues. These stereotypes have consequences, whether political, legal, or within the medical system, and may prevent people from seeking care that can help.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Cannabis Law Report

MARCH 19, 2022

Publishing online and in print with open access options, Psychedelic Medicine will provide an authoritative, high-profile forum for groundbreaking original research papers, review articles, captivating front matter, debate, and commentary. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Cannabis Law Report

JULY 13, 2022

The table below sets out the TGA’s priority areas for compliance activities relating to the import, advertising and supply requirements of the Therapeutic Goods Act 1989 from 1 July 2022 to 30 June 2023. The public promotion of prescription medicines can inappropriately influence demand and disrupt the doctor/patient relationship.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. oz of 5% or less THC oil for medical patients with qualifying conditions. The only way to access the plant and its products is through the legacy market (aka the black market).

Law 96

Law Decriminalization Programs Patients 96

The Cannigma

JULY 12, 2022

Unlike other states, Alabama requires doctors to document a failure of conventional medical treatment before issuing a medical cannabis prescription. As of June 2022, there is no way for medical patients to obtain a cannabis prescription or get medication. Possible penalties for cannabis. The cost of a prescription is unknown.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Veriheal

JUNE 20, 2023

Depression and addiction continue to impact millions of lives worldwide, making the search for effective treatments crucial. In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine.

Medicine 98

Medicine Research and Development Treatment Conditions 98

Veriheal

SEPTEMBER 15, 2023

Though Georgia is one of the last states to officially legalize medical cannabis, the state has been gradually reforming its laws around low-THC cannabis oil for qualifying patients. Finally, on April 28, 2023, the first licensed sales commenced with the opening of dispensaries in Marietta and Macon.

Programs 62

Programs Legalization Oil Conditions 62

Veriheal

MARCH 31, 2023

Study Analyzes Cannabis’ Effects on Tourettes Patients A new study published in the journal Cannabis and Cannabinoid Research looked at how medical cannabis could improve the lives of those with Tourettes syndrome. The study enlisted the help of 70 patients with Tourettes. Let’s dive into this week’s cannanews.

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora expects LPH-5 to be IND ready in Q4 2022 and plans to begin first-in-human trials in 2023.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Veriheal

SEPTEMBER 2, 2022

MMJ Patients Is on the Rise. As more patients have sought out legal medical cannabis patient status in the country, it is believed that the number of registered U.K. medical cannabis patients now exceeds 17,000. estimates that 60-70% of his patients are seeking out medical cannabis for the treatment of chronic pain.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

PrestoDoctor

FEBRUARY 13, 2023

Louis Skyline – Gateway Arch Getting your Missouri medical marijuanas card in 2023 is still beneficial. Learn about how to become a medical marijuana patient so you can get access to medical cannabis in Missouri. Qualifying patients may be certified by an MD, DO, or a nurse practitioner.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

Cannabis Law Report

JUNE 8, 2022

Experienced healthcare leaders bring decades of experience in global drug commercialization and patient access. MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial.

Therapy 52

Therapy Treatment Access Patients 52

Veriheal

JUNE 1, 2023

Thus, Weiner pulled it out from consideration until 2023. ” He said the legislation is an important step because people will “have access to substances that they need that are not addictive.” Patients would go through at least 30 sessions lasting at least 12 hours.

Legalization 91

Legalization Decriminalization Legislation Therapy 91

SpeedWeed

MAY 22, 2021

This work builds capacity to deliver quality, accessible care to patients, pending approval of MDMA-assisted therapy as a legal prescription treatment.”. Fortunately, MAPS has already conducted several clinical studies confirming that this treatment is both safe and effective.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Cannabis Law Report

JANUARY 27, 2022

If passed the bill will establish the “Task Force on Psilocybin Equity” that will research problems relating to access and equity in Oregon’s emerging psilocybin program. The task force will complete a study and provide policy recommendations that will serve as a basis for substantive policy reforms during the 2023 legislative session.

Research and Development 52

Research and Development Policy Access Legislation 52

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. Commercial Operations. Traditionally Regulated Medical Practice. Underground Therapists.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

SpeedWeed

MAY 15, 2021

For this study, researchers recruited 90 patients suffering from severe, chronic PTSD. For 88% of people who receive this treatment, we can expect to see a treatment response. MAPS is now enrolling participants for a further Phase 3 study that will allow another 50 subjects to access this promising new therapy.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

SEPTEMBER 16, 2022

The program is a “limited license” regime, under which a set number of vertically integrated “Medical Marijuana Treatment Centers” are licensed to cultivate, process, and dispense cannabis to qualified patients. Arkansas dispensaries began serving qualified patients in 2019. In 2021, more than $1.2 Code § 16-12-191.

Law 52

Law Programs Cultivation Dispensary 52

Medicinal Genomics

JANUARY 10, 2024

In 2023, CannMed transformed into an Innovation and Investment Summit held at the J.W. We share videos of all the CannMed presentations for free in the CannMed Archives because we believe access to quality information should not be limited. Marriott Marco Island Beach Resort, Marco Island, FL.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

SEPTEMBER 22, 2022

SB 1186– Medicinal Cannabis Patients’ Right of Access Act. The bill’s author, Senator Scott Weiner, states this bill is a victory for seniors living with chronic illness, and will both improve patient access and help fill voids throughout the state where no cannabis license types have been authorized. FOOTNOTES. [1]

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] Defining Psychedelics. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

MARCH 29, 2023

However, a 2023 study debunks many myths about the potential dangers of legalizing cannabis. In addition, several other studies suggest that legalizing access to marijuana is actually associated with decreased: Crime Opioid overdose Mental illness rates Gone are the days when cautionary tales run rampant. 1, 2003, to Dec.

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

SEPTEMBER 7, 2022

law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. ’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C.

Patients 97

Patients Programs Access Treatment 97

The Joint Blog

AUGUST 15, 2019

The measures signed by Governor Pritzker not only adds additional ways in which patients can access medical cannabis and adds 11 new qualifying medical conditions, but it makes the state’s medical marijuana program – which up until this point has been a pilot program – a permanent fixture of the law.

Programs 29

Programs Chronic Pain Marijuana Patients 29

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105

MMJ Recs

JUNE 1, 2024

Along with the increasing acceptance of cannabis , the state has witnessed a surge in convenient delivery services, bringing the plant’s benefits directly to patients’ doorsteps. It’s a development that promises to streamline operations for cannabis delivery companies and enhance accessibility for patients.

Access 52

Access Patients Medicine Dispensary 52

Cannabis Law Report

DECEMBER 21, 2021

billion in 2023. Ignite products are ecologically responsible and do not require additional wastewater treatment. Genomics test results allow practitioners and patients to set individualized, trackable goals around pharmacogenomics (PGx), cannabis DNA, nutrition DNA, and fitness DNA for personalized health and wellness.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JANUARY 9, 2022

The state’s medical patients (about 0.5% Of the cannabis-related tax revenue it collects, the state distributes 40% to public schools, 15% to law enforcement, and 25% to mental health and treatment programs. Starting on July 1, 2023 and thereafter, 25% of the excise tax will go to the Prevention and Recovery Services Fund.

Collective 52

Collective Policy Retail Programs 52

Veriheal

JANUARY 24, 2024

A late 2023 poll could provide insight into upcoming reform in the Florida cannabis market. In 2023, the state’s Division of Elections revealed that over one million Floridians voted to see the adult use of cannabis added to the ballot for imminent general elections.

Recreational 62

Recreational History Cannabis Legalization 62